CO4750671A1 - Preparaciones antigenicas y procedimientos para su produccion - Google Patents
Preparaciones antigenicas y procedimientos para su produccionInfo
- Publication number
- CO4750671A1 CO4750671A1 CO96042293A CO96042293A CO4750671A1 CO 4750671 A1 CO4750671 A1 CO 4750671A1 CO 96042293 A CO96042293 A CO 96042293A CO 96042293 A CO96042293 A CO 96042293A CO 4750671 A1 CO4750671 A1 CO 4750671A1
- Authority
- CO
- Colombia
- Prior art keywords
- asmp
- glycopeptides
- yeasts
- polysaccharides
- derived
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 230000000890 antigenic effect Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000463 material Substances 0.000 abstract 7
- 241000233866 Fungi Species 0.000 abstract 2
- 102000002068 Glycopeptides Human genes 0.000 abstract 2
- 108010015899 Glycopeptides Proteins 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- 238000000926 separation method Methods 0.000 abstract 2
- 239000006228 supernatant Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/72—Candida
- C12R2001/725—Candida albicans
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/921—Candida
- Y10S435/922—Candida albicans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Procedimiento para la preparación de un material solubleantigénico que comprende polisacáridos y/o glicopéptidos (ASMP), caracterizado porque células fungicidas que pertenecen al grupo de hongos queratinofílicos o levaduras, o un material de las mismas - se tratan bajo condiciones alcalinas acuosas, - se separan las fases sólidas y líquidas de la preparación, - después de la separación, el material sobrenadante se trata con un ácido mineral u orgánico, y - después de la separación se precipita el ASMP a partir del material sobrenadante. 1Un material que comprende polisacáridos y/o glicopéptidos, que tiene actividad anti-alérgica en mamíferos, derivándose dicho material, o pudiéndose derivar, de hongos queratinofílicos o levaduras, o de un material de los mismos, por técnicas de aislamiento apropiadas, por ejemplo las definidas en una cualquiera de las reivindicaciones 1, 3 y 5.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9516461A GB2304347A (en) | 1995-08-11 | 1995-08-11 | Antigenic preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4750671A1 true CO4750671A1 (es) | 1999-03-31 |
Family
ID=10779086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO96042293A CO4750671A1 (es) | 1995-08-11 | 1996-08-09 | Preparaciones antigenicas y procedimientos para su produccion |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6379678B1 (es) |
| EP (1) | EP0863991B1 (es) |
| JP (3) | JP4285768B2 (es) |
| KR (1) | KR100447926B1 (es) |
| CN (1) | CN1228450C (es) |
| AR (1) | AR008982A1 (es) |
| AT (1) | ATE253641T1 (es) |
| AU (1) | AU717731B2 (es) |
| CA (1) | CA2229203C (es) |
| CO (1) | CO4750671A1 (es) |
| CZ (1) | CZ294394B6 (es) |
| DE (1) | DE69630611T2 (es) |
| DK (1) | DK0863991T3 (es) |
| ES (1) | ES2206588T3 (es) |
| GB (1) | GB2304347A (es) |
| HU (1) | HU224223B1 (es) |
| IL (1) | IL123153A (es) |
| MX (1) | MX9801180A (es) |
| NZ (1) | NZ316062A (es) |
| PL (1) | PL186523B1 (es) |
| PT (1) | PT863991E (es) |
| RU (1) | RU2245721C2 (es) |
| SK (1) | SK282746B6 (es) |
| WO (1) | WO1997007232A1 (es) |
| ZA (1) | ZA966801B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020959C1 (ru) * | 1991-10-21 | 1994-10-15 | Игорь Дмитриевич Поляков | Вакцина поливак-тм для профилактики и лечения дерматофитозов животных |
| GB2304347A (en) * | 1995-08-11 | 1997-03-19 | Boeringer Ingelheim Vetmedica | Antigenic preparations |
| EP0834322A3 (en) * | 1996-10-04 | 1998-04-22 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Mycosis vaccine |
| AU3547499A (en) * | 1998-03-31 | 1999-10-18 | Abbott Laboratories | Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof |
| CA2325063A1 (en) * | 2000-10-27 | 2002-04-27 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence | Method for detecting antibodies to and antigens of fungal and yeast exposures |
| CN104147597A (zh) * | 2002-12-16 | 2014-11-19 | 全球免疫股份有限公司 | 用于免疫治疗的基于酵母的疫苗 |
| US9820986B2 (en) * | 2005-03-04 | 2017-11-21 | Taiwan Hopaz Chems, Mfg. Co., Ltd. | Glycopeptide compositions |
| WO2010032139A1 (en) * | 2008-09-17 | 2010-03-25 | Hunter Immunology Limited | Bacterial and fungal vaccines for the treatment of asthma |
| RU2660365C1 (ru) * | 2015-11-20 | 2018-07-05 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) | Способ получения специфических антигенных препаратов из клинически значимых дрожжевых грибов |
| HRP20211604T1 (hr) * | 2016-03-15 | 2022-01-21 | Igor Polyakov | Kompozicije za liječenje i prevenciju bolesti kopita i kandži |
| US11173193B2 (en) | 2016-03-15 | 2021-11-16 | Igor Polyakov | Immunobiological products |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3867555A (en) * | 1972-11-29 | 1975-02-18 | Anheuser Busch | Manufacture of yeast protein isolate having a reduced nucleic acid content by an alkali process |
| FR2338287A1 (fr) * | 1976-01-19 | 1977-08-12 | Idemitsu Kosan Co | Polysaccharide ayant la propriete de former un gel et procede microbiologique pour sa preparation |
| JPS536413A (en) * | 1976-07-07 | 1978-01-20 | Kureha Chem Ind Co Ltd | Preparation of n-containing polysaccharides |
| NO153458C (no) * | 1978-06-07 | 1986-03-26 | Inst Experimentalnoi Veterinar | Fremgangsm¨te for fremstilling av vaksine for profylakse o g behandling av ringorm hos pelsdyr og kaniner for¨rsaket av trichophyton mentagrophytes. |
| AU547928B2 (en) * | 1981-11-03 | 1985-11-14 | Sutka, K. | Antigenic preparation from candida guilliermondii |
| GB8506373D0 (en) * | 1985-03-12 | 1985-04-11 | Axon Healthcare Ltd | Antigens antibodies |
| GB8913737D0 (en) | 1989-06-15 | 1989-08-02 | Univ Birmingham | A novel anti-allergy treatment |
| US5223491A (en) * | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
| WO1991015878A1 (de) | 1990-04-09 | 1991-10-17 | Adalbert Kopera | Antennenanordnung |
| US5277904A (en) * | 1990-10-26 | 1994-01-11 | Pier Allan C | Broad spectrum dermatophyte vaccine |
| RU2020959C1 (ru) | 1991-10-21 | 1994-10-15 | Игорь Дмитриевич Поляков | Вакцина поливак-тм для профилактики и лечения дерматофитозов животных |
| EP0714412A1 (en) | 1993-08-19 | 1996-06-05 | Minnesota Mining And Manufacturing Company | Heparin functional affinity supports |
| AUPM473294A0 (en) * | 1994-03-25 | 1994-04-21 | Franklyn, Kathleen Mary | Peptides for diagnostics and therapeutics |
| GB2304347A (en) | 1995-08-11 | 1997-03-19 | Boeringer Ingelheim Vetmedica | Antigenic preparations |
| EP0834322A3 (en) | 1996-10-04 | 1998-04-22 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Mycosis vaccine |
-
1995
- 1995-08-11 GB GB9516461A patent/GB2304347A/en not_active Withdrawn
-
1996
- 1996-08-09 IL IL12315396A patent/IL123153A/en not_active IP Right Cessation
- 1996-08-09 PT PT96928443T patent/PT863991E/pt unknown
- 1996-08-09 ES ES96928443T patent/ES2206588T3/es not_active Expired - Lifetime
- 1996-08-09 DK DK96928443T patent/DK0863991T3/da active
- 1996-08-09 US US09/011,018 patent/US6379678B1/en not_active Expired - Lifetime
- 1996-08-09 HU HU9802419A patent/HU224223B1/hu active IP Right Grant
- 1996-08-09 WO PCT/EP1996/003535 patent/WO1997007232A1/en active IP Right Grant
- 1996-08-09 CA CA2229203A patent/CA2229203C/en not_active Expired - Lifetime
- 1996-08-09 KR KR10-1998-0700994A patent/KR100447926B1/ko not_active IP Right Cessation
- 1996-08-09 CZ CZ1998400A patent/CZ294394B6/cs not_active IP Right Cessation
- 1996-08-09 AU AU68207/96A patent/AU717731B2/en not_active Expired
- 1996-08-09 NZ NZ316062A patent/NZ316062A/xx not_active IP Right Cessation
- 1996-08-09 RU RU98104502/15A patent/RU2245721C2/ru active
- 1996-08-09 SK SK177-98A patent/SK282746B6/sk not_active IP Right Cessation
- 1996-08-09 EP EP96928443A patent/EP0863991B1/en not_active Expired - Lifetime
- 1996-08-09 AT AT96928443T patent/ATE253641T1/de active
- 1996-08-09 DE DE69630611T patent/DE69630611T2/de not_active Expired - Lifetime
- 1996-08-09 CO CO96042293A patent/CO4750671A1/es unknown
- 1996-08-09 CN CNB961975717A patent/CN1228450C/zh not_active Expired - Lifetime
- 1996-08-09 MX MX9801180A patent/MX9801180A/es active IP Right Grant
- 1996-08-09 JP JP50892197A patent/JP4285768B2/ja not_active Expired - Lifetime
- 1996-08-09 PL PL96324975A patent/PL186523B1/pl unknown
- 1996-08-12 AR ARP960103948A patent/AR008982A1/es not_active Suspension/Interruption
- 1996-08-12 ZA ZA966801A patent/ZA966801B/xx unknown
-
2002
- 2002-03-22 US US10/103,133 patent/US7090857B2/en not_active Expired - Lifetime
-
2008
- 2008-06-18 JP JP2008158819A patent/JP4286312B2/ja not_active Expired - Lifetime
- 2008-06-18 JP JP2008158818A patent/JP4286311B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4750671A1 (es) | Preparaciones antigenicas y procedimientos para su produccion | |
| ES2106146T3 (es) | Procedimiento de produccion de una substancia que contiene lipoproteina con un contenido en lipidos reducido. | |
| ES2088425T3 (es) | Metodo de produccion de xilitol a partir de mezclas que contienen xilosa. | |
| ES2054676T3 (es) | Regulacion de transcripcion especifica de semillas. | |
| GR3005297T3 (es) | ||
| AR240332A1 (es) | Composiciones para facilitar la extraccion de articulos moldeados de poliables, composiciones de poliables que las contienen. | |
| MX169089B (es) | Metodo para convertir almidon en un producto hidrolizado | |
| PT95830A (pt) | Processo para o isolamento do factor viii sob a forma de uma fraccao pura directamente de plasma mediante filtracao em gel | |
| ES8407064A1 (es) | "procedimiento para la preparacion de compuestos de la serie de los glicolipidos regeneradores de celulas y tejidos" | |
| KR870000031A (ko) | 고려인삼 엑기스의 추출법 | |
| BG100765A (en) | Process for the preparation of salt of clavulanic acid | |
| GB505983A (en) | Improvements in the manufacture and production of pharmaceutically active substances | |
| HK80591A (en) | Process for the preparation of camomile extracts rich in flavone | |
| DE60017108D1 (de) | Lösungsmittelextraktionsverfahren | |
| KR860002274A (ko) | 저장성 카모밀레 추출물의 제조방법 | |
| DE60002099D1 (de) | Apfelbaumstengeln extrakten für die verwendung in dermatokosmetik und verfahren zu deren herstellung | |
| NO994852D0 (no) | En ny prosess for aa fremstille stabilisert höykonsentrert diterpenfenolsyre | |
| CO5280143A1 (es) | Mutantes de ehv gm-negativa | |
| ES556273A0 (es) | Procedimiento para la separacion y el aislamiento del nosiheptido | |
| ES2061731T3 (es) | Procedimiento de extraccion de antigenos de membrana con propiedades inmunogenicas de celulas neoplasicas humanas y los productos asi obtenidos. | |
| JPS6442412A (en) | Skin-beautifying cosmetic | |
| IT1006629B (it) | Processo per la preparazione di oli bianchi tecnici ed oli medicinali | |
| SE8202138L (sv) | Forfarande for isolering av (+)-usninsyra fran usnea barbata l | |
| PE20010394A1 (es) | Procedimiento para la extraccion de lipidos a partir de material biologico | |
| JPS5718620A (en) | Production of antitumor substance |